Remitly director exercises option and sells 5,000 shares under 10b5-1 plan

Rhea-AI Filing Summary

Remitly Global director Phillip John Riese reported option exercise and concurrent share sale on 09/05/2025. He exercised a stock option with a $0.64 exercise price to acquire 5,000 shares and immediately sold 5,000 shares under a Rule 10b5-1 trading plan at a weighted average price of $20.00 to $20.02. Following these transactions he beneficially owned 112,496 common shares and held derivative securities representing 485,000 underlying shares. The reporting was signed by an attorney-in-fact on 09/09/2025. The filing notes the option became fully vested and exercisable on December 15, 2017.

Positive

• Sale executed under a Rule 10b5-1 trading plan, indicating the transaction was pre-planned
• Option exercise price of $0.64 and sale proceeds at a weighted average of approximately $20.00 per share created clear realized value
• Option was fully vested since December 15, 2017, showing no recent vesting acceleration

Negative

• Decrease in direct beneficial ownership by 5,000 common shares (from 117,496 to 112,496)
• Insider sold shares which represents a partial divestment of holdings

Insights

Securities/Equity Analyst

TL;DR: Routine insider exercise and sale executed under a 10b5-1 plan; results in a modest reduction in outstanding personal common shares.

The filing documents a contemporaneous exercise of an in-the-money option at $0.64 and an immediate sale of the same number of shares under a pre-established Rule 10b5-1 plan at roughly $20.00 each, crystallizing value from longstanding equity compensation. This is a standard liquidity event for insiders and reduces the reporting person’s direct common stock holdings from 117,496 to 112,496 shares while leaving material derivative exposure of 485,000 underlying shares.

Corporate Governance Expert

TL;DR: Transaction followed formal trading-plan mechanics, suggesting pre-planned liquidity rather than opportunistic trading.

The Form 4 explicitly indicates the sale was effected pursuant to a Rule 10b5-1 trading plan, which provides an affirmative defense to insider trading claims when conditions are met. The report also discloses that the exercised option was fully vested since 2017, indicating no recent acceleration of vesting. From a governance perspective this is a documented, routine insider monetization event with transparent disclosure.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Riese Phillip John

(Last) (First) (Middle)

C/O REMITLY GLOBAL, INC.

401 UNION STREET, SUITE 1000

(Street)

SEATTLE WA 98101

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Remitly Global, Inc. [ RELY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/05/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/05/2025		M		5,000	A	$0.64	117,496	D
Common Stock	09/05/2025		S(1)		5,000	D	$20(2)	112,496	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$0.64	09/05/2025		M			5,000	(3)	01/30/2027	Common Stock	5,000	$0	485,000	D

Explanation of Responses:

1. This transaction was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

2. Weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.02 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

3. The option became fully vested and exercisable on December 15, 2017.

Remarks:

	/s/ Jeff Mason as attorney-in-fact	09/09/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Remitly (RELY) director Phillip John Riese do on 09/05/2025?

He exercised a stock option at a $0.64 exercise price to acquire 5,000 shares and sold 5,000 shares under a Rule 10b5-1 plan at a weighted average price of $20.00 to $20.02.

How many shares does Phillip John Riese beneficially own after the reported transactions?

Following the transactions he beneficially owned 112,496 common shares and held derivative securities representing 485,000 underlying shares.

Was the sale pre-planned or discretionary?

The filing states the sale was effected automatically pursuant to a Rule 10b5-1 trading plan, indicating it was pre-planned.

What price were the shares sold at in the Form 4 filing?

The shares were sold at a weighted average price reported as $20.00 to $20.02; the filer offered to provide exact per-price breakdowns upon request.

When did the option exercised become fully vested?

The option became fully vested and exercisable on December 15, 2017.